Next quarter’s earnings estimate for APOG is $0.99 with a range of $0.86 to $1.16. The previous quarter’s EPS was $1.14. APOG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 64.84% of the time in the same period. In the last calendar year APOG has Outperformed its overall industry.

APOG Sales Forecast

Next quarter’s sales forecast for APOG is $328.47M with a range of $328.00M to $329.10M. The previous quarter’s sales results were $361.84M. APOG beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 60.61% of the time in the same period. In the last calendar year APOG has Underperformed its overall industry.

Detailed List of Analyst Forecasts

Brent Thielman

D.A. Davidson

$50.00

Hold

-18.29%

Downside

Reiterated

12/26/23

Analysts Offer Insights on Industrial Goods Companies: Wabash National (NYSE: WNC) and Apogee (NASDAQ: APOG)

Alex Thompson CFA

Stifel Nicolaus

$34.00

Buy

-44.44%

Downside

Initiated

08/08/23

Stifel starts Apogee Therapeutics Inc (APGE) at BuyStifel analyst Alex Thompson initiates coverage on Apogee Therapeutics Inc (NASDAQ: APGE) with a Buy rating and a price target of $34.00.

Eric Stine

Craig-Hallum

$51.00

Hold

-16.65%

Downside

Assigned

06/26/23

Analysts Offer Insights on Industrial Goods Companies: Knife River Corporation (KNF) and Apogee (APOG) - TipRanks.comIn a report released today, Eric Stine from Craig-Hallum maintained a Hold rating on Apogee. The companys shares closed last Friday at $43.15.

Unknown Analyst

Not Ranked

Singular

$60.50

Buy

-1.13%

Downside

Reiterated

01/09/24

Apogee Enterprises (APOG) PT Raised to $60.50 at Singular ResearchSingular Research analyst BJ Cook raised the price target on Apogee Enterprises (NASDAQ: APOG) to $60.50 (from $56.50) while maintaining a Buy rating.

Unknown Analyst

Not Ranked

BTIG

$43.00

Buy

-29.73%

Downside

Initiated

12/20/23

BTIG starts Apogee Therapeutics Inc (APGE) at Buy, We See Apogee Developing Dominant Therapies for IL-13/4R? Mediated II DiseasesBTIG analyst Julian Harrison initiates coverage on Apogee Therapeutics Inc (NASDAQ: APGE) with a Buy rating and a price target of $43.00.

Best Analysts Covering Apogee

Which Analyst Should I Follow If I Want to Buy APOG and Sell After:

1 Month

Alex Thompson CFAStifel Nicolaus

Success Rate

0/1 ratings generated profit

Average Return

-1.40%

initiated a buy rating 9 months ago

Copying Alex Thompson CFA's trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -1.40% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

Go Premium

3 Months

Alex Thompson CFAStifel Nicolaus

Success Rate

0/1 ratings generated profit

Average Return

-10.70%

initiated a buy rating 9 months ago

Copying Alex Thompson CFA's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -10.70% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

Go Premium

1 Year

Alex Thompson CFAStifel Nicolaus

Success Rate

1/1 ratings generated profit

Average Return

+16.70%

initiated a buy rating 9 months ago

Copying Alex Thompson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +16.70% per trade.

2 Years

Alex Thompson CFAStifel Nicolaus

Success Rate

1/1 ratings generated profit

Average Return

+16.70%

initiated a buy rating 9 months ago

Copying Alex Thompson CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +16.70% per trade.

dummydummy

Success Rate

0/0 ratings generated profit

Average Return

0.00%

a rating ―

Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.

Premium Content

Find out which analyst has the highest Average Return & Success Rate

Go Premium

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

APOG Analyst Recommendation Trends

Rating

Aug 23

Sep 23

Nov 23

Dec 23

Jan 24

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, APOG has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. APOG average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Industrial Goods Sector

xxxxxxxxxxxxxxx

Find stocks in the Industrial Goods sector that are highly recommended by Top Performing Analysts.

APOG Stock Forecast FAQ

What is APOG’s average 12-month price target, according to analysts?

Currently, no data Available

What is APOG’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for APOG, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is APOG a Buy, Sell or Hold?

Currently, no data Available

What is Apogee Enterprises’s price target?

Currently, no data Available

What do analysts say about Apogee Enterprises?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of APOG?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Apogee (APOG) Stock Forecast & Price Target

APOG Analyst Ratings

APOG Stock 12 Month Forecast

APOG Financial Forecast

APOG Earnings Forecast

APOG Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering Apogee

APOG Analyst Recommendation Trends

APOG Stock Forecast FAQ

Get More with TipRanks Premium

Detailed List of Analyst Forecasts